0001810705-23-000001.txt : 20230112 0001810705-23-000001.hdr.sgml : 20230112 20230112124358 ACCESSION NUMBER: 0001810705-23-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230112 DATE AS OF CHANGE: 20230112 EFFECTIVENESS DATE: 20230112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Transposon Therapeutics, Inc. CENTRAL INDEX KEY: 0001810705 IRS NUMBER: 843996895 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-469103 FILM NUMBER: 23525503 BUSINESS ADDRESS: STREET 1: 2765 SAND HILL ROAD STREET 2: C/O CANAAN PARTNERS CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (949) 422-9676 MAIL ADDRESS: STREET 1: 2765 SAND HILL ROAD STREET 2: C/O CANAAN PARTNERS CITY: MENLO PARK STATE: CA ZIP: 94025 D/A 1 primary_doc.xml X0708 D/A LIVE 0001810705 Transposon Therapeutics, Inc. 4660 La Jolla Village Drive Suites 100 & 200 San Diego CA CALIFORNIA 92122 (858) 535-4821 DELAWARE None None Corporation true 2019 Lynne R. Rollins 4660 La Jolla Village Drive Suites 100 & 200 San Diego CA CALIFORNIA 92122 Executive Officer Eckard Weber, MD 4660 La Jolla Village Drive Suites 100 & 200 San Diego CA CALIFORNIA 92122 Executive Officer Director Brent Ahrens 4660 La Jolla Village Drive Suites 100 & 200 San Diego CA CALIFORNIA 92122 Director John Pacifico 4660 La Jolla Village Drive Suites 100 & 200 San Diego CA CALIFORNIA 92122 Director William Harrington, MD, MBA 4660 La Jolla Village Drive Suites 100 & 200 San Diego CA CALIFORNIA 92122 Director Daniel Hetu, MD, MBA 4660 La Jolla Village Drive Suites 100 & 200 San Diego CA CALIFORNIA 92122 Director Keith A. Katkin 4660 La Jolla Village Drive Suites 100 & 200 San Diego CA CALIFORNIA 92122 Director Brian Taylor Slingsby, MD, PHD, MPH 4660 La Jolla Village Drive Suites 100 & 200 San Diego CA CALIFORNIA 92122 Director Dennis Podlesak 4660 La Jolla Village Drive Suites 100 & 200 San Diego CA CALIFORNIA 92122 Director Pharmaceuticals Decline to Disclose 06b true 0001810705-22-000002 2022-12-20 false true true true false 0 20020000 5005000 15015000 false 8 0 0 0 false Transposon Therapeutics, Inc. Lynne R. Rollins Lynne R. Rollins Chief Financial Officer 2023-01-12